Related Experiment Video
Updated: Jun 13, 2025

Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
Altered Gut Microbiome Composition and Function in Individuals with Complex Regional Pain Syndrome.
Emmanuel Gonzalez1, Tali Sahar2, May Haddad3
1McGill Centre for Microbiome Research, McGill University, Montreal, Quebec, Canada; Canadian Center for Computational Genomics, McGill University and Genome Quebec Innovation Center, Montreal, Quebec, Canada; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Complex regional pain syndrome (CRPS) is linked to distinct gut microbiome changes, including altered short-chain fatty acid bacteria and metabolites. These microbiome differences can accurately identify CRPS patients.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Complex regional pain syndrome (CRPS) is a chronic pain condition with unclear mechanisms.
- CRPS involves severe pain, autonomic dysfunction, and motor symptoms, with limited treatment options.
- The gut microbiome's role in chronic pain is increasingly recognized, necessitating investigation in CRPS.
Purpose of the Study:
- To investigate the gut microbiome composition and function in individuals with CRPS.
- To compare the gut microbiomes of CRPS patients with those of healthy controls.
- To identify potential diagnostic biomarkers and therapeutic targets for CRPS within the gut microbiome.
Main Methods:
- 16S rRNA gene sequencing was used to analyze the gut microbiome composition in CRPS patients and controls.
- Targeted metabolomic analysis of fecal and plasma samples was performed to assess bacteria-derived metabolites.
- Machine learning algorithms were employed to classify CRPS patients based on their microbiome profiles.
Main Results:
- Significant differences in bacterial taxa, particularly short-chain fatty acid (SCFA)-metabolizing species, were observed between CRPS patients and controls.
- Altered levels of fecal and plasma SCFAs were confirmed in CRPS patients.
- Microbiome composition alone achieved accurate classification of CRPS patients in an independent validation cohort.
Conclusions:
- The gut microbiome exhibits unique compositional and functional alterations in individuals with CRPS.
- These findings support the gut microbiome's involvement in the pathophysiology of CRPS.
- The study suggests potential for novel diagnostic and therapeutic strategies targeting the gut microbiome in CRPS.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
10:32In Vitro Recording of Mesenteric Afferent Nerve Activity in Mouse Jejunal and Colonic Segments
Published on: October 25, 2016
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Analgesia and Pain Management